跳至主要内容
临床试验/JPRN-UMIN000000647
JPRN-UMIN000000647未知1 期

To evaluate safety and efficacy of intravitreal Bevaxizumab injection for intraocular neovasculalization - Intravitreal Bevaxizumab injection for intraocular neovasculalization

Department of Ophtalmology of Keio University Hospital0 个研究点目标入组 10 人开始时间: 2007年3月22日最近更新:
适应症

试验速览

阶段
1 期
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Cr>3.0mg/dL anstable angina malignant arrhythmia HT:140/80mmHg>

研究者

发起方
Department of Ophtalmology of Keio University Hospital

相似试验

进行中(未招募)
不适用
Evaluation of safety and efficacy of intravitreal bevacizumab for macular edema, retinal or choroidal neovascularization or neovascular glaucoma - NDMacular oedemaMedDRA version: 6.1Level: HLGTClassification code 10047060
EUCTR2006-002351-33-ITAZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA
进行中(未招募)
不适用
Evaluation of efficacy and safety of Intravitreal bevacizumab versus intravitreal bevacizumab combined with juxtascleral anecortave acetate for the treatment exudative age-related macular degeneration - IVB JSA
EUCTR2006-003170-99-ITIVERSITA DEGLI STUDI DI UDINE
已完成
不适用
Safety and effectiveness of intravitreal bevacizumab and ranibizumab injections for treatment of retinal disease patients: an observational studyretinal diseases or conditions that can be treated with bevacizumab or ranibizumab such as neovascular age&#45related macular degeneration (neovascular AMD)&#44diabetic macular edema (DME)&#44and macular edeneovascular age&#45related macular degeneration (neovascular AMD)diabetic macular edema (DME)retinal vein occlusion(RVO)
TCTR20141002001Health Intervention and Technology Assessment Program (HITAP)6,399
进行中(未招募)
不适用
Safety and efficacy of intravitreal injections of ranibizumab/Lucentis in combination with verteporfin photodynamic therapy (PDT) in patients with choroidal neovascularisation (CNV) secondary to age related macular degeneratio
EUCTR2006-002977-33-SIniversity Eye Hospital10
已完成
不适用
Evaluation of the efficacy and safety of intravitreal injection of ranibizumab every other month for age-related macular degeneratioage-related macular degeneration
JPRN-UMIN000005691Department of Ophthalmology, Shiga University of Medical Science40